mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.6 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.6 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |